DVAX vs ELAN
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DVAX is a Hold and ELAN is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
DVAX’s FA Score shows that 0 FA rating(s) are green whileELAN’s FA Score has 0 green FA rating(s).
- DVAX’s FA Score: 0 green, 5 red.
- ELAN’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
DVAX’s TA Score shows that 4 TA indicator(s) are bullish while ELAN’s TA Score has 5 bullish TA indicator(s).
- DVAX’s TA Score: 4 bullish, 5 bearish.
- ELAN’s TA Score: 5 bullish, 5 bearish.
Price Growth
DVAX (@Pharmaceuticals: Other) experienced а -16.95% price change this week, while ELAN (@Pharmaceuticals: Other) price change was +22.67% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.06%. For the same industry, the average monthly price growth was +12.42%, and the average quarterly price growth was +15.65%.
Reported Earning Dates
DVAX is expected to report earnings on Jul 31, 2025.
ELAN is expected to report earnings on Aug 11, 2025.
Industries' Descriptions
@Pharmaceuticals: Other (-0.06% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
| DVAX | ELAN | DVAX / ELAN | |
| Capitalization | 1.62B | 7.87B | 21% |
| EBITDA | 9.67M | -224M | -4% |
| Gain YTD | -26.312 | -1.239 | 2,124% |
| P/E Ratio | 31.63 | N/A | - |
| Revenue | 232M | 4.42B | 5% |
| Total Cash | 742M | 352M | 211% |
| Total Debt | 257M | 5.77B | 4% |
DVAX | ELAN | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 63 | 20 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 70 Overvalued | 88 Overvalued | |
PROFIT vs RISK RATING 1..100 | 62 | 100 | |
SMR RATING 1..100 | 82 | 81 | |
PRICE GROWTH RATING 1..100 | 87 | 41 | |
P/E GROWTH RATING 1..100 | 98 | 97 | |
SEASONALITY SCORE 1..100 | 95 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
DVAX's Valuation (70) in the Biotechnology industry is in the same range as ELAN (88) in the Agricultural Commodities Or Milling industry. This means that DVAX’s stock grew similarly to ELAN’s over the last 12 months.
DVAX's Profit vs Risk Rating (62) in the Biotechnology industry is somewhat better than the same rating for ELAN (100) in the Agricultural Commodities Or Milling industry. This means that DVAX’s stock grew somewhat faster than ELAN’s over the last 12 months.
ELAN's SMR Rating (81) in the Agricultural Commodities Or Milling industry is in the same range as DVAX (82) in the Biotechnology industry. This means that ELAN’s stock grew similarly to DVAX’s over the last 12 months.
ELAN's Price Growth Rating (41) in the Agricultural Commodities Or Milling industry is somewhat better than the same rating for DVAX (87) in the Biotechnology industry. This means that ELAN’s stock grew somewhat faster than DVAX’s over the last 12 months.
ELAN's P/E Growth Rating (97) in the Agricultural Commodities Or Milling industry is in the same range as DVAX (98) in the Biotechnology industry. This means that ELAN’s stock grew similarly to DVAX’s over the last 12 months.
| DVAX | ELAN | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 83% | 1 day ago 80% |
| Stochastic ODDS (%) | 1 day ago 80% | 1 day ago 82% |
| Momentum ODDS (%) | 1 day ago 71% | 1 day ago 58% |
| MACD ODDS (%) | 1 day ago 77% | 1 day ago 64% |
| TrendWeek ODDS (%) | 1 day ago 77% | 1 day ago 65% |
| TrendMonth ODDS (%) | 1 day ago 76% | 1 day ago 65% |
| Advances ODDS (%) | 11 days ago 76% | 3 days ago 62% |
| Declines ODDS (%) | 1 day ago 80% | 5 days ago 74% |
| BollingerBands ODDS (%) | 1 day ago 80% | 1 day ago 68% |
| Aroon ODDS (%) | 1 day ago 78% | 1 day ago 79% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| HAIL | 27.31 | 0.60 | +2.25% |
| SPDR® S&P Kensho Smart Mobility ETF | |||
| HAUZ | 21.91 | 0.16 | +0.73% |
| Xtrackers International Real Estate ETF | |||
| RLTY | 15.24 | 0.11 | +0.73% |
| Cohen & Steers Real Estate Opportunities and Income Fund | |||
| FAAR | 26.84 | 0.12 | +0.45% |
| First Trust Alt Abs Ret Strat ETF | |||
| SPHY | 23.18 | 0.02 | +0.09% |
| SPDR® Portfolio High Yield Bond ETF | |||